Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

1.

Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.

Cassim N, Coetzee LM, Schnippel K, Glencross DK.

PLoS One. 2014 Dec 17;9(12):e115420. doi: 10.1371/journal.pone.0115420. eCollection 2014.

3.

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.

Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG; CHER Study Team.

Lancet. 2013 Nov 9;382(9904):1555-63. doi: 10.1016/S0140-6736(13)61409-9.

4.

Piloting a national laboratory electronic programme status reporting system.

Cassim N, Coetzee L, Motlonye B, Mpele N, Glencross DK.

Stud Health Technol Inform. 2013;192:1146.

PMID:
23920920
5.

Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations.

Bergeron M, Daneau G, Ding T, Sitoe NE, Westerman LE, Stokx J, Jani IV, Coetzee LM, Scott L, De Weggheleire A, Boel L, Stevens WS, Glencross DK, Peter TF.

PLoS One. 2012;7(8):e41166. doi: 10.1371/journal.pone.0041166. Epub 2012 Aug 9. Erratum in: PLoS One. 2012;7(9). doi: 10.1371/annotation/71a6d947-c034-4749-a33d-971284ea3408.

6.

Decentralised CD38 activation monitoring: aspects of practical implementation and standardisation.

Moodley K, Coetzee LM, Glencross DK.

J Immunol Methods. 2012 Apr 30;378(1-2):121-7. doi: 10.1016/j.jim.2012.02.013. Epub 2012 Mar 3.

PMID:
22398190
7.

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy.

Wallis CL, Papathanasopolous MA, Fox M, Conradie F, Ive P, Orrell C, Zeinecker J, Sanne I, Wood R, McIntyre J, Stevens W; CIPRA-SA project 1 study team.

Antivir Ther. 2012;17(2):313-20. doi: 10.3851/IMP1985. Epub 2011 Nov 18.

8.

Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa.

Glencross DK, Coetzee LM, Faal M, Masango M, Stevens WS, Venter WF, Osih R.

J Int AIDS Soc. 2012 Jan 30;15(1):3. doi: 10.1186/1758-2652-15-3.

9.

Providing immediate CD4 count results at HIV testing improves ART initiation.

Faal M, Naidoo N, Glencross DK, Venter WD, Osih R.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e54-9. doi: 10.1097/QAI.0b013e3182303921.

PMID:
21857356
10.

Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.

Conradie F, Foulkes AS, Ive P, Yin X, Roussos K, Glencross DK, Lawrie D, Stevens W, Montaner LJ, Sanne I, Azzoni L.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):309-18. doi: 10.1097/QAI.0b013e31822e0d15.

11.

Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational study.

Azzoni L, Foulkes AS, Firnhaber C, Yin X, Crowther NJ, Glencross D, Lawrie D, Stevens W, Papasavvas E, Sanne I, Montaner LJ.

J Int AIDS Soc. 2011 Jul 29;14:37. doi: 10.1186/1758-2652-14-37.

12.

Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.

Firnhaber C, Azzoni L, Foulkes AS, Gross R, Yin X, Van Amsterdam D, Schulze D, Glencross DK, Stevens W, Hunt G, Morris L, Fox L, Sanne I, Montaner LJ.

PLoS One. 2011;6(6):e21450. doi: 10.1371/journal.pone.0021450. Epub 2011 Jun 28.

13.

Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.

Papasavvas E, Azzoni L, Foulkes A, Violari A, Cotton MF, Pistilli M, Reynolds G, Yin X, Glencross DK, Stevens WS, McIntyre JA, Montaner LJ.

Pediatr Infect Dis J. 2011 Oct;30(10):877-82. doi: 10.1097/INF.0b013e31821d141e.

14.

Possibilities never contemplated: 20 lessons.

Glencross D.

Afr J Psychiatry (Johannesbg). 2010 Nov;13(5):338, 340. No abstract available.

15.

Comprehensive & cost effective laboratory monitoring of HIV/AIDS: an African role model.

Lawrie D, Janossy G, Roos M, Glencross DK.

J Vis Exp. 2010 Oct 31;(44). pii: 2312. doi: 10.3791/2312.

PMID:
21085099
16.

Association between HIV replication and serum leptin levels: an observational study of a cohort of HIV-1-infected South African women.

Azzoni L, Crowther NJ, Firnhaber C, Foulkes AS, Yin X, Glencross D, Gross R, Kaplan MD, Papasavvas E, Schulze D, Stevens W, van der Merwe T, Waisberg R, Sanne I, Montaner LJ.

J Int AIDS Soc. 2010 Sep 7;13:33. doi: 10.1186/1758-2652-13-33.

17.
18.

Tree-Based Methods for Discovery of Association between Flow Cytometry Data and Clinical Endpoints.

Eliot M, Azzoni L, Firnhaber C, Stevens W, Glencross DK, Sanne I, Montaner LJ, Foulkes AS.

Adv Bioinformatics. 2009;2009:235320. doi: 10.1155/2009/235320. Epub 2010 Jan 21.

19.

Reduced variance in monozygous twins for multiple MR parameters: implications for disease studies and the genetic basis of brain structure.

Pell GS, Briellmann RS, Lawrence KM, Glencross D, Wellard RM, Berkovic SF, Jackson GD.

Neuroimage. 2010 Jan 15;49(2):1536-44. doi: 10.1016/j.neuroimage.2009.09.003. Epub 2009 Sep 9.

PMID:
19747554
20.

Polychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).

Murdoch DM, Suchard MS, Venter WD, Mhlangu P, Ottinger JS, Feldman C, Van Rie A, Glencross DK, Stevens WS, Weinhold KJ.

AIDS Res Ther. 2009 Jul 16;6:16. doi: 10.1186/1742-6405-6-16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk